Last reviewed · How we verify
NCT03878017
A Novel Method of Clipped Axillary Lymph Node Localization Post Neoadjuvant Chemotherapy in Breast Cancer Patients .
NA trial testing skin marking of clip axillary lymph node for localisation in Breast Cancer Female in 15 participants. Status unknown.
30 October 2020
Quick facts
| Lead sponsor | KK Women's and Children's Hospital |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 15 |
| Start date | 1 March 2017 |
| Primary completion | 30 October 2020 |
| Estimated completion | 30 October 2020 |
| Sites | 1 location across Singapore |
Drugs / interventions tested
- skin marking of clip axillary lymph node for localisation
Conditions studied
- Breast Cancer Female — all drugs for Breast Cancer Female →
Sponsor
KK Women's and Children's Hospital
Who can join
Adults 21 to 80, female only, with Breast Cancer Female. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
to determine the feasibility of a novel technique of localization of clipped LN post neoadjuvant chemotherapy
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Initial results of a novel technique of clipped node localization in breast cancer patients postneoadjuvant chemotherapy: Skin Mark clipped Axillary nodes Removal Technique (SMART trial).
Lim GH, Teo SY, Gudi M, Ng RP, et al · · 2020 · cited 26× · PMID 31970894 · DOI 10.1002/cam4.2848 -
Would Removal of All Ultrasound Abnormal Metastatic Lymph Nodes Without Sentinel Lymph Node Biopsy Be Accurate in Patients with Breast Cancer with Neoadjuvant Chemotherapy?
Lim GH, Gudi M, Teo SY, Ng RP, et al · · 2020 · cited 22× · PMID 32537791 · DOI 10.1634/theoncologist.2020-0494 -
Targeted axillary dissection in breast cancer patients with metastatic nodal disease: a prospective study on localization techniques and oncological outcomes.
Lim GH, Al Shukairi AM, Lee YS, Teo SY, et al · · 2025 · PMID 40948928 · DOI 10.21037/gs-2025-166
Verify or expand the search:
- PubMed search for NCT03878017
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Breast Cancer Female
Currently open trials in the same condition.
- NCT07505797 — ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE) · recruiting
- NCT07198724 — ERADICATE: A Phase Ib/II Study of Elacestrant Plus Trastuzumab Deruxtecan in Patients With CDK4/6 Inhibitor and Endocrin · Phase 1, PHASE2 · recruiting
- NCT07331506 — Validation of the Oncoliq Test for the Early Detection of Breast Cancer. · recruiting
- NCT07214883 — UCF MammoChat: Image Repository · recruiting
- NCT07120100 — Transcranial Magnetic Stimulation for Chemotherapy-Induced Peripheral Neuropathy in Breast and Gynecologic Cancer Surviv · NA · recruiting
Other KK Women's and Children's Hospital trials
Trials by the same sponsor.
- NCT07534670 — Early Pregnancy Lifestyle and Glucose Patterns: A Substudy of TOFFFY · NA · not yet recruiting
- NCT07466797 — The eHealth Integrated Maternal Physical Activity Programme in Prenatal Care Trial (E-IMPACT) · NA · recruiting
- NCT06457750 — Anthropometric Outcomes of a Mobile Health Intervention for Eating Behaviour and Lifestyle in Infancy · NA · not yet recruiting
- NCT06481644 — Asia Pediatric Intensive Care Epidemiology and Outcomes Study · recruiting
- NCT06489834 — Group Drumming for Improving the Health of Community-Dwelling Elderly · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03878017 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by KK Women's and Children's Hospital
- Last refreshed: 21 February 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03878017.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing